Coherus as Marketing and Distribution Partner for Bioeq and Its Biosimilar to Lucentis (ranibizumab) in the US
Bioeq announced that it signed a license and development agreement with Coherus BioSciences, under which Coherus will exclusively market and distribute Bioeq's biosimilar candidate to Lucentis (ranibizumab) in the United States. Coherus BioSciences is a leading biosimilar company that develops and